Innovation Biomedical Center
View of the Innovation Biomedical Center.
The management of the IEM decided to establish the Innovation Biomedical Center (IBC) on the basis of medical market demand and in an effort to enhance the innovative potential of the IEM´s scientific outputs and the effectiveness of their transfer to medical practice. The innovation process is essentially wedded to entrepreneurship; therefore the IBC’ s
activities are oriented towards the support and development
of small spin-off firms.
activities are oriented towards the support and development
of small spin-off firms.
The Innovation Biomedical Center is a newly built facility located in the close vicinity of the Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, in Prague-Krč. It was constructed from August 2007 to March 2008. The project was financed with contributions from the EU and the city of Prague.
The Science and Technology Parks Association of the CR awarded the Innovation Biomedicine Center accreditation in October 2008.
The goal of the IBC project is to build the complex infrastructure necessary for technology transfer from the IEM through applied research and innovative entrepreneurship to the medical market place.
The vision of the IBC is to become the key center in the field of cell-based therapies and their transfer to medical practice in the Czech Republic, and to take part in world networks in this field.
The mission of the IBC is to stimulate research outputs and their commercialization by providing favorable conditions for the emergence and development of spin-off firms with innovative potential in the field of biomedicine.
The IBC promotes the use of IEM technology to benefit the IEM through licensing inventions to spin-off companies capable of successfully commercializing them. It supports the research mission of the IEM by finding industrial partners for spin-off firms, sponsoring research and generating licensing income that supports future research. The IBC earns a fair return and increases the recognition of the IEM and the inventors, thus contributing to the growth of the spin-off firms and the development of the IEM. The IBC helps move technologies from the IEM’s laboratories to the marketplace by developing and managing an array of partnerships with the private sector. Successful technology transfer involves a number of steps, beginning with the invention of new technology. These inventions are evaluated, then if appropriate, intellectual property protection (patents or copyright) is sought. 
Collaborative research with industry may further develop the technology, which may then be promoted and, hopefully, licensed.
